This study’s authors claimed that their study showed that getting a tattoo increased risk, but their data actually suggested ...

Celastrol, a herbal compound in traditional Chinese medicine, may help prevent BPD-PH by reducing inflammation and protecting ...

A dietary change that included a decrease in dietary omega-6 and an increase in omega-3 fatty acids could reduce prostate ...

The US Food and Drug Administration has accepted Sobi’s supplemental biologics licence application for Gamifant ...

US FDA grants priority review to Sobi’s sBLA for Gamifant for use in adult and paediatric patients with HLH/MAS in Still’s disease: Stockholm Friday, February 28, 2025, 09:00 ...

The U.S. Food and Drug Administration (FDA) has accepted Sobi’s supplemental Biologics License Application (sBLA) for ...

Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) ...

Gamifant® (emapalumab-Izsg) a monoclonal antibody that binds and neutralises interferon gamma (IFN-y), was approved by the FDA in 2018 for the treatment of adult and paediatric (newborn and older) ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

Porcine reproductive and respiratory syndrome virus (PRRSV) infection in pigs is economically devastating for the global ...

LTZ Therapeutics, an immunotherapy-focused biotech company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for ...

Capricor Therapeutics filed a BLA for deramiocel, showing promising results in slowing cardiac dysfunction in DMD ...